BRPI1008349A2 - derivados de piperidina tal como antagonistas de receptor de nk3 - Google Patents
derivados de piperidina tal como antagonistas de receptor de nk3Info
- Publication number
- BRPI1008349A2 BRPI1008349A2 BRPI1008349A BRPI1008349A BRPI1008349A2 BR PI1008349 A2 BRPI1008349 A2 BR PI1008349A2 BR PI1008349 A BRPI1008349 A BR PI1008349A BR PI1008349 A BRPI1008349 A BR PI1008349A BR PI1008349 A2 BRPI1008349 A2 BR PI1008349A2
- Authority
- BR
- Brazil
- Prior art keywords
- receptor antagonists
- piperidine derivatives
- piperidine
- derivatives
- antagonists
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09151722 | 2009-01-30 | ||
| PCT/EP2010/050591 WO2010086259A1 (en) | 2009-01-30 | 2010-01-19 | Piperidine derivatives as nk3 receptor antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI1008349A2 true BRPI1008349A2 (pt) | 2016-02-23 |
Family
ID=42077990
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI1008349A BRPI1008349A2 (pt) | 2009-01-30 | 2010-01-19 | derivados de piperidina tal como antagonistas de receptor de nk3 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US8324248B2 (pt) |
| EP (1) | EP2391615B1 (pt) |
| JP (1) | JP5399518B2 (pt) |
| KR (1) | KR101372743B1 (pt) |
| CN (1) | CN102282139B (pt) |
| AU (1) | AU2010209825A1 (pt) |
| BR (1) | BRPI1008349A2 (pt) |
| CA (1) | CA2747961C (pt) |
| ES (1) | ES2402000T3 (pt) |
| IL (1) | IL213769A0 (pt) |
| MX (1) | MX2011007506A (pt) |
| SG (1) | SG173114A1 (pt) |
| WO (1) | WO2010086259A1 (pt) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2331500A1 (en) * | 2008-10-09 | 2011-06-15 | F. Hoffmann-La Roche AG | Pyrrolidine n-benzyl derivatives |
| WO2016028971A1 (en) | 2014-08-21 | 2016-02-25 | Bristol-Myers Squibb Company | Tied-back benzamide derivatives as potent rock inhibitors |
| WO2017072629A1 (en) | 2015-10-29 | 2017-05-04 | Cadila Healthcare Limited | Pharmaceutical combination of nk3 receptor antagonist and biguanides |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2738819B1 (fr) * | 1995-09-14 | 1997-12-05 | Sanofi Sa | Nouveaux composes antagonistes selectifs du recepteur nk3 humain, procede pour leur obtention et compositions pharmaceutiques les contenant |
| CN1867549B (zh) * | 2003-08-15 | 2011-07-06 | H·隆德贝克有限公司 | 作为nk3受体拮抗剂的环丙基衍生物 |
| EP1748984A1 (en) * | 2004-05-12 | 2007-02-07 | Pfizer Products Inc. | Piperidine derivatives as nk1 and nk3 antagonists |
| JP2007084530A (ja) * | 2005-08-22 | 2007-04-05 | Sankyo Co Ltd | インダノール誘導体を含有する医薬組成物 |
| TW201018662A (en) * | 2005-12-12 | 2010-05-16 | Astrazeneca Ab | Alkylsulphonamide quinolines |
| RU2009119393A (ru) * | 2006-12-07 | 2011-01-20 | Ф. Хоффманн-Ля Рош Аг (Ch) | Производные спиропиперидина |
| US7470684B2 (en) * | 2007-01-03 | 2008-12-30 | Hoffmann-La Roche Inc. | Spiropiperidine derivatives as NK3 antagonists |
| JP2007314554A (ja) * | 2007-07-13 | 2007-12-06 | Schering Plough Corp | ニューロキニンアンタゴニストとしてのピペリジン誘導体 |
| ATE517100T1 (de) | 2007-08-07 | 2011-08-15 | Hoffmann La Roche | Pyrrolidinarylether als nk3-rezeptorantagonisten |
| JP2010536818A (ja) | 2007-08-22 | 2010-12-02 | エフ．ホフマン−ラ ロシュ アーゲー | Ｎｋ３受容体アンタゴニストとしてのピロリジンアリール−エーテル |
| US8063075B2 (en) * | 2008-06-10 | 2011-11-22 | Hoffmann-La Roche Inc. | Pyrrolidine ether derivatives as NK3 receptor antagonists |
-
2010
- 2010-01-19 SG SG2011053345A patent/SG173114A1/en unknown
- 2010-01-19 JP JP2011546779A patent/JP5399518B2/ja not_active Expired - Fee Related
- 2010-01-19 WO PCT/EP2010/050591 patent/WO2010086259A1/en active Application Filing
- 2010-01-19 EP EP10700438A patent/EP2391615B1/en not_active Not-in-force
- 2010-01-19 ES ES10700438T patent/ES2402000T3/es active Active
- 2010-01-19 CA CA2747961A patent/CA2747961C/en not_active Expired - Fee Related
- 2010-01-19 BR BRPI1008349A patent/BRPI1008349A2/pt not_active IP Right Cessation
- 2010-01-19 MX MX2011007506A patent/MX2011007506A/es active IP Right Grant
- 2010-01-19 CN CN201080004810.4A patent/CN102282139B/zh not_active Expired - Fee Related
- 2010-01-19 KR KR1020117019521A patent/KR101372743B1/ko not_active IP Right Cessation
- 2010-01-19 AU AU2010209825A patent/AU2010209825A1/en not_active Abandoned
- 2010-01-25 US US12/692,680 patent/US8324248B2/en not_active Expired - Fee Related
-
2011
- 2011-06-23 IL IL213769A patent/IL213769A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL213769A0 (en) | 2011-07-31 |
| EP2391615B1 (en) | 2013-01-16 |
| US20100197697A1 (en) | 2010-08-05 |
| CA2747961A1 (en) | 2010-08-05 |
| US8324248B2 (en) | 2012-12-04 |
| AU2010209825A1 (en) | 2011-08-11 |
| ES2402000T3 (es) | 2013-04-26 |
| WO2010086259A1 (en) | 2010-08-05 |
| CA2747961C (en) | 2016-11-08 |
| JP2012516297A (ja) | 2012-07-19 |
| JP5399518B2 (ja) | 2014-01-29 |
| KR20110111312A (ko) | 2011-10-10 |
| EP2391615A1 (en) | 2011-12-07 |
| KR101372743B1 (ko) | 2014-03-14 |
| MX2011007506A (es) | 2011-08-04 |
| SG173114A1 (en) | 2011-08-29 |
| CN102282139A (zh) | 2011-12-14 |
| CN102282139B (zh) | 2014-06-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI1013821A2 (pt) | piridinas substituídas como antagonistas de ccr3. | |
| BRPI0821141A2 (pt) | Derivados de heteroarila como antagonistas do receptor de orexina | |
| BRPI0812981A2 (pt) | Derivados de piperidina úteis como antagonistas dos receptores de orexina | |
| BRPI0909157A2 (pt) | compostos heterocíclicos como antagonistas de receptores de adenosina | |
| BRPI1016189A2 (pt) | compostos de 4-azetidinil-1-fenil-ciclohexano antagonistas de ccr2 | |
| ZA201007126B (en) | Isoquinolinone derivatives as nk3 antagonists | |
| BRPI0810462A2 (pt) | Derivados de quinolina-carboxamida como antagonistas de p2y12 | |
| BRPI0817245A2 (pt) | Derivados e quinolina como antagonistas receptores de 5ht5a | |
| DK2821407T3 (da) | Piperidinoncarboxamidazaindan-cgrp receptorantagonister | |
| BRPI0815674A2 (pt) | Aril-éter de pirrolidina como antagonista de receptor de nk3 | |
| BRPI0815658A2 (pt) | Aril-éter pirrolidina como antagonistas do receptor nk3 | |
| BRPI0814767A2 (pt) | Derivados de monoamida como antagonistas do receptor de orexina | |
| BRPI1013617A2 (pt) | derivados de piperidina como antagonistas de receptor de nk3 | |
| BR112012003976A2 (pt) | antagonistas de receptor glyt1 carbocíclico | |
| BRPI1007369A2 (pt) | derivados de di-hidroquinolinona | |
| SMT201300020B (it) | Derivati di isochinolinone come antagonisti dei recettori nk3 | |
| CO6811856A2 (es) | Derivados de la piperidina 3-espirocíclica como agonistas de receptores de la ghrelina | |
| IL212107A0 (en) | Isoquinolinone derivatives as nk3 antagonists | |
| IL209663A0 (en) | Isoquinolinone derivatives as nk3 antagonists | |
| BRPI0916333A2 (pt) | piridinas substituídas por piperazin-1-il-trifluorometila como antagonistas do receptor de dopamina 2 de rápida dissociação | |
| BRPI0822693A2 (pt) | Derivados de quinuclidina como antagonistas do receptor muscarínico m3 | |
| BRPI0914797A2 (pt) | derivados de éter de pirrolidina como antagonistas do receptor de nk3 | |
| BRPI0914779A2 (pt) | derivados de pirrolidina como antagonistas de receptor de nk2 | |
| IL217759A0 (en) | Pyrrolidine derivatives as nk3 receptor antagonists | |
| BRPI1012775A2 (pt) | piperidinas substituídas |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 9A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2497 DE 13-11-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |